A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.
about
A novel RNA transcript with antiapoptotic function is silenced in fragile X syndromeFragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutationThe fragile-X premutation: a maturing perspective.Fragile X-associated tremor/ataxia syndrome.Modeling Fragile X Syndrome Using Human Pluripotent Stem CellsAging in individuals with the FMR1 mutation.Identifying intrinsic and extrinsic determinants that regulate internal initiation of translation mediated by the FMR1 5' leader.Whole genome microarray analysis of gene expression in subjects with fragile X syndrome.Advances in understanding the molecular basis of FXTASAging in fragile X syndrome.Testing the FMR1 promoter for mosaicism in DNA methylation among CpG sites, strands, and cells in FMR1-expressing males with fragile X syndrome.Role of 5'- and 3'-untranslated regions of mRNAs in human diseases.Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations.A small molecule that targets r(CGG)(exp) and improves defects in fragile X-associated tremor ataxia syndrome.FMR1 epigenetic silencing commonly occurs in undifferentiated fragile X-affected embryonic stem cellsFragile X mental retardation protein in plasticity and disease.Rare intranuclear inclusions in the brains of 3 older adult males with fragile x syndrome: implications for the spectrum of fragile x-associated disordersDecreased fragile X mental retardation protein expression underlies amygdala dysfunction in carriers of the fragile X premutation.Bromodomain inhibitors regulate the C9ORF72 locus in ALSAnalysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models.Fragile X syndrome: an aging perspective.Destabilization of tetraplex structures of the fragile X repeat sequence (CGG)n is mediated by homolog-conserved domains in three members of the hnRNP family.Fragile X-associated tremor/ataxia syndrome (FXTAS): pathology and mechanisms.Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the fieldEmerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders.The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.The roles of Sp1, Sp3, USF1/USF2 and NRF-1 in the regulation and three-dimensional structure of the Fragile X mental retardation gene promoterRNA biology of disease-associated microsatellite repeat expansions.In sickness and in health: the importance of translational regulation.Relevance of corpus callosum splenium versus middle cerebellar peduncle hyperintensity for FXTAS diagnosis in clinical practice.Reevaluation of FMR1 Hypermethylation Timing in Fragile X Syndrome.Of Men and Mice: Modeling the Fragile X Syndrome.FXS-Like Phenotype in Two Unrelated Patients Carrying a Methylated Premutation of the Gene
P2860
Q21562300-39DC22E5-6D93-4261-9FAB-B7B0D8762815Q24533431-46D5EE7A-2A7F-4E40-87AC-93C2E9CCF949Q24533443-B7805488-9B3F-4796-9BBB-B1287BFCAA59Q26852667-D9E3EBE3-370F-4E39-A60A-45F15AC1C4E6Q28080022-F8D4C2D3-BF39-4D4D-AE1C-A2852EE23A46Q30909849-B1178415-4664-4954-ADEF-6DAA80176BE2Q33376873-72B71E6E-C46F-44E6-BE98-83FDD7E980E7Q33752522-8DE255B8-5D2F-4D67-8280-B9AF7A8990C1Q33871325-C135C2BC-5436-43B3-BE11-BDA9021A6061Q33901217-4199F821-DB61-4D57-BB4A-A625AD6C26A3Q34016335-E2ACFFF7-8E01-489E-98CD-B00A94A99FD0Q34016479-0EE99375-C8AC-4DAB-9651-F155D868EFE3Q34364858-79654F4E-F452-416A-8CFE-EBC7609EB4D6Q34403150-01477A54-62BB-4A57-9218-8363FE6B6B38Q34530652-20FB9CE4-67A9-483C-82F8-3A849D95D71FQ34993137-B9F7D024-F297-4010-9540-31A1D368E7D4Q35027822-0B9F0017-D4AB-4517-BD5C-832F5D1430ADQ35317411-E8AC4929-241F-4D83-A9C0-07FB89076ABCQ35670978-5C3F6DE5-9E51-4B7B-99BB-20444C2F079FQ35752822-8CE6B0B9-F43A-4EA6-9CC8-DB796E7E74D5Q37122910-5D35977C-5384-4C9F-B7EA-312BE7837A9BQ37483297-C29849D1-296B-43B6-B7AB-9E21F5EB509FQ37524454-2D195588-4199-468A-8807-7F70DDD57759Q37580522-B1244D4B-C09B-4AEB-8665-6AE7DE94A624Q37623407-32F97961-E70E-41AA-8EDA-39301D3ADA53Q37989144-6392B8A2-12AB-49AA-AFB2-08B6E1C83EACQ38760301-3F93B0A2-6C99-4CD1-87B5-F8C1077B4333Q39681923-4292EB66-51B7-4F74-9750-E7CCFA2AE9D0Q40505209-14EB2C62-E753-498D-8162-B04E9CA6B602Q41542861-77FD3169-7315-4F33-B9B1-5C819C3F3FD9Q42109005-A32944A9-864C-4F62-B4AF-DB82B6B5C2DAQ48433730-37275BEF-4763-473E-9C7F-5C1C4805F117Q50166708-6B0CED3A-165E-49A4-BAF2-2BE1022CF352Q53422584-C25A1E4E-4BDB-4170-A6C2-2F96C763BBB3Q59137486-64673E8C-671F-46D8-A283-EEC8900C04F2
P2860
A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1 messenger RNA.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@ast
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@en
type
label
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@ast
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@en
prefLabel
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@ast
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@en
P2093
P356
P1476
A majority of fragile X males ...... levels of FMR1 messenger RNA.
@en
P2093
A K Taylor
P J Hagerman
R J Hagerman
P304
P356
10.1136/JMG.38.7.453
P407
P577
2001-07-01T00:00:00Z